Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,028 | 25,306 | 41,722 | 32,773 | 26,850 |
| Marketable Securities | 81,636 | 114,856 | 119,077 | 151,341 | 178,143 |
| Receivables | N/A | N/A | 305 | 960 | 873 |
| TOTAL | $124,468 | $144,558 | $165,538 | $189,820 | $211,681 |
| Non-Current Assets | |||||
| PPE Net | 9,896 | 11,160 | 12,288 | 13,895 | 15,113 |
| Investments And Advances | 2,154 | 2,154 | 2,154 | 2,154 | 2,154 |
| Other Non-Current Assets | 37,183 | 39,081 | 41,123 | 42,068 | 43,336 |
| TOTAL | $49,233 | $52,395 | $55,565 | $58,117 | $60,603 |
| Total Assets | $173,701 | $196,953 | $221,103 | $247,937 | $272,284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,603 | 2,398 | 1,489 | 1,215 | 2,891 |
| Accrued Expenses | 7,596 | 4,690 | 6,719 | 9,897 | 5,924 |
| TOTAL | $27,632 | $22,499 | $22,933 | $29,583 | $33,265 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,198 | 9,306 | 8,700 | 12,900 | 18,942 |
| Other Non-Current Liabilities | 33,502 | 35,034 | 36,585 | 38,011 | 39,635 |
| TOTAL | $33,502 | $36,669 | $39,574 | $39,907 | $43,188 |
| Total Liabilities | $61,134 | $59,168 | $62,507 | $69,490 | $76,453 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,777 | 37,647 | 37,621 | 37,547 | 37,533 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -361,411 | -333,929 | -310,870 | -288,342 | -267,949 |
| Other shareholders' equity | -122 | -44 | 260 | 371 | 372 |
| TOTAL | $112,567 | $137,785 | $158,596 | $178,447 | $195,831 |
| Total Liabilities And Equity | $173,701 | $196,953 | $221,103 | $247,937 | $272,284 |